Telo Ebit from 2010 to 2024

TELO Stock  CAD 0.12  0.01  9.09%   
Telo Genomics EBIT yearly trend continues to be fairly stable with very little volatility. EBIT will likely drop to about -2.7 M in 2024. During the period from 2010 to 2024, Telo Genomics EBIT regression line of quarterly data had r-squared of  0.11 and coefficient of variation of (116.76). View All Fundamentals
 
EBIT  
First Reported
2012-12-31
Previous Quarter
-672.5 K
Current Value
-834 K
Quarterly Volatility
730.6 K
 
Yuan Drop
 
Covid
Check Telo Genomics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Telo Genomics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 54.5 K, Selling General Administrative of 1.6 M or Other Operating Expenses of 2.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 7.0. Telo financial statements analysis is a perfect complement when working with Telo Genomics Valuation or Volatility modules.
  
This module can also supplement various Telo Genomics Technical models . Check out the analysis of Telo Genomics Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Telo Stock Analysis

When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.